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Human Dermis Harbors Distinct Mesenchymal
Stromal Cell Subsets
Christine Vaculik1, Christopher Schuster1, Wolfgang Bauer1, Nousheen Iram1, Karin Pfisterer2, Gero Kramer3,
Andreas Reinisch4, Dirk Strunk4,5 and Adelheid Elbe-Bu¨rger1
Multipotent mesenchymal stromal cells (MSCs) are found in a variety of adult tissues including human dermis.
These MSCs are morphologically similar to bone marrow–derived MSCs, but are of unclear phenotype. To shed
light on the characteristics of human dermal MSCs, this study was designed to identify and isolate dermal MSCs
by a specific marker expression profile, and subsequently rate their mesenchymal differentiation potential.
Immunohistochemical staining showed that MSC markers CD73/CD90/CD105, as well as CD271 and SSEA-4, are
expressed on dermal cells in situ. Flow cytometric analysis revealed a phenotype similar to bone
marrow–derived MSCs. Human dermal cells isolated by plastic adherence had a lower differentiation capacity
as compared with bone marrow–derived MSCs. To distinguish dermal MSCs from differentiated fibroblasts, we
immunoselected CD271þ and SSEA-4þ cells from adherent dermal cells and investigated their mesenchymal
differentiation capacity. This revealed that cells with increased adipogenic, osteogenic, and chondrogenic
potential were enriched in the dermal CD271þ population. The differentiation potential of dermal SSEA-4þ
cells, in contrast, appeared to be limited to adipogenesis. These results indicate that specific cell populations
with variable mesenchymal differentiation potential can be isolated from human dermis. Moreover, we
identified three different subsets of dermal mesenchymal progenitor cells.
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INTRODUCTION
The major obstacle for the identification of multipotent
mesenchymal stromal cells (MSC) is their morphological and
phenotypical similarity to fibroblasts. Even 40 years after their
first description, no definite cell surface marker is available
that reliably identifies MSCs and enables their isolation
(Friedenstein et al., 1966). Rather, a variety of markers are
used for the identification of MSCs. Recently, the multitude of
cell surface markers used in various studies has been limited
to a marker panel representing, in addition to plastic
adherence and differentiation capacity, the minimal criteria
for the identification of MSCs (Dominici et al., 2006). These
markers, however, do not discriminate between MSCs and
fibroblasts (Haniffa et al., 2009) and partially overlap with
other cell lineages. Nevertheless, the prevailing method for
the isolation of MSCs irrespective of the original tissue is
plastic adherence, which in turn leads to the selection of a
very heterogeneous starting population (Ho et al., 2008).
Therefore, a number of approaches have been undertaken to
identify cell surface markers that hold promise for a specific
isolation of MSCs from various tissues that include CD49a
(Deschaseaux et al., 2003), CD105 (Conconi et al., 2006),
CD271 (Quirici et al., 2002; Bu¨hring et al., 2007), GD2
(Martinez et al., 2007), SSEA-4 (Gang et al., 2007), and
STRO-1 (Simmons and Torok-Storb, 1991). Apart from bone
marrow, MSCs have been isolated from a variety of other
tissues, such as umbilical cord blood (Erices et al., 2000;
Mareschi et al., 2001), adipose tissue (Miyazaki et al., 2005;
Gimble et al., 2007), placenta (Fukuchi et al., 2004; Miao
et al., 2006; Battula et al., 2007), synovial fluid (Jones et al.,
2004), fibrous and adipose synovium (Mochizuki et al.,
2006), pancreas (Seeberger et al., 2006; Gallo et al., 2007),
and dermis (Yates et al., 2001; Young et al., 2001; Bartsch
et al., 2005; Chen et al., 2007; Lysy et al., 2007).
The main focus of cutaneous stem cell research is on
epidermal stem cells and stem cells associated with the hair
follicle. However, various studies proved the presence of
mesenchymal progenitors also in the dermis. Skin-derived
precursors with the capacity of neural and mesodermal
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differentiation were obtained from nonadherent dermal cells
(Yates et al., 2001; Young et al., 2001; Bartsch et al., 2005;
Toma et al., 2005; Chen et al., 2007; Lysy et al., 2007). Other
studies, in contrast, identified mesenchymal progenitor cells
within the fraction of plastic-adherent dermal cells (Bartsch
et al., 2005; Chen et al., 2007; Lysy et al., 2007; Lorenz et al.,
2008). Among other cell types, adherent dermal cells include
fibroblasts, which are the prevailing cell type in the dermis
and are of a yet not fully understood physiological hetero-
geneity (Sorrell et al., 2007). In addition, adherent dermal
cells contain subsets that are capable of differentiating into
osteoblasts, adipocytes, chondrocytes (Lorenz et al., 2008),
and myocytes (Bartsch et al., 2005). Even ectodermal and
endodermal potential has been assigned to these cells (Chen
et al., 2007; Lysy et al., 2007). When using cell surface
markers commonly used for the characterization of MSCs, the
phenotype of dermal fibroblasts was largely similar to that of
bone marrow–derived MSCs (Ishii et al., 2005; Wagner et al.,
2005; Chen et al., 2007). There are, however, approaches to
identify phenotypically distinct progenitor cells from overall
fibroblasts. Chen et al. (2007) identified a nestinvimentinþ
multipotent dermal fibroblast and thereby provide evidence
for the possible isolation of progenitor subsets from dermal
adherent cells.
The goal of our study was to characterize MSCs in human
dermis and isolate progenitor cell subsets based on a specific
phenotype for further investigation.
RESULTS
MSC markers are expressed on various dermal cell types
The presence of mesenchymal stem/progenitor cells in
human dermis has been reported previously (Toma et al.,
2001; Yates et al., 2001; Young et al., 2001; Bartsch et al.,
2005; Chen et al., 2007; Lysy et al., 2007). As their
phenotype is still poorly characterized, we analyzed the
expression of MSC markers in human dermis. In situ analysis
of skin cryosections by immunohistochemical staining
revealed that MSC markers (CD73, CD90, CD105, CD271,
SSEA-4) are expressed on different dermal cell types
(Figure 1a, upper panel). CD73, CD90, and CD105 show
similar single-cell, vascular and perivascular expression
patterns (Figure 1a, inset, lower panel). It is noteworthy that
CD90 is also faintly expressed on some basal keratinocytes,
thus confirming previous results (Nakamura et al., 2006). In
contrast, CD271 is present on cutaneous nerve fibers,
Schwann cells, dermal single cells, and, faintly, on clusters
of basal keratinocytes as reported (Figure 1a, inset, lower
panel; Liang et al., 1999; Nakamura et al., 2007). The dermal
expression pattern of SSEA-4 is almost analogous to CD271.
As SSEA-4 expression has been demonstrated on neural cells
(Dodd and Jessell, 1986; Holford et al., 1994; Barraud et al.,
2007), we conclude that SSEA-4 is also expressed on neural
structures in human dermis and, to a lesser extent, on dermal
single cells. These observations confirm the shared expres-
sion of markers used for the identification of MSCs by a
variety of cell types (Kolf et al., 2007). For a more detailed
analysis of dermal cell populations expressing MSC markers,
we double- and triple-stained dermal single-cell suspensions
and analyzed them by flow cytometry. The marker combina-
tions were selected to define cell types typically found in
human dermis, such as endothelial cells (CD31þ , CD34þ )
and leukocytes (CD45þ ). As a marker for ‘‘contaminating’’
keratinocytes, we used CD318 (Brown et al., 2004). Apart
from CD73þ , CD90þ , and CD105þ cells co-expressing
CD31 and CD34 or CD45, we identified CD73þ , CD90þ ,
and CD105þ cells lacking endothelial and leukocyte
CD73 CD90 CD105 CD271 SSEA-4
Figure 1. Expression of MSC markers in human dermis. (a) Immunohistochemistry staining for the indicated markers (brown) of human foreskin. Nuclei were
counterstained with hematoxylin (blue). (b) Evaluation of expression of multipotent mesenchymal stromal cell (MSC) markers on CD31þ endothelial cells,
CD45þ leukocytes, and CD318þ keratinocytes by multiparameter flow cytometry of freshly isolated cells of human foreskin was performed by incubation with
mAb against the indicated cell surface markers. Dot plots display 2.5104 cells (donor age: 3–8 years, n¼ 6). Histograms display CD34 expression of
gated double-positive cells (black rectangles). Dead cells were excluded by 7-amino-actinomycin-D uptake. Quadrants in dot plots were set according to
isotype-matched control staining. Y-axis label applies to all dot plots in a row. Bar (a, upper panel)¼200 mm, (a, lower panel)¼ 50 mm.
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Figure 1. Continued.
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markers, thus rendering these cells potential mesenchymal
progenitor cells (Figure 1b; Dominici et al., 2006). CD271
and SSEA-4, in contrast, were only negligibly expressed on
endothelial cells in human dermis, but we detected small
populations of CD271þCD45þ cells and SSEA-4þCD45þ
cells. Corroborating our immunohistochemistry staining, we
found expression of CD318 only on a small population of
CD271þ and CD90þ cells, which are most probably
keratinocyte stem/progenitor cells (Figure 1b; Liang et al.,
1999). CD318þ cells occur in variable numbers in dermal
single-cell suspensions and represent epithelial cells derived
from skin appendages and epidermal cells (Brown et al.,
2004) as contaminants of the incomplete removal of the
epidermis during the skin preparation procedure.
Adherent dermal cells have MSC characteristics
To test whether adherent dermal cells harbor mesenchymal
progenitors, they were subjected to mesenchymal differentia-
tion assays. Similar to previous observations (Yates et al.,
2001; Young et al., 2001; Bartsch et al., 2005; Chen et al.,
2007; Lysy et al., 2007; Lorenz et al., 2008), we found that
human dermis contains cells capable of differentiating into
osteoblasts and adipocytes (Figure 2a), whereas we could
never observe chondrogenic differentiation of adherent
dermal cells without further enrichment (data not shown).
Adipogenic and osteogenic differentiation was confirmed by
molecular analysis in comparison with negative controls
using peroxisome proliferator–activated receptor-g-2 or alka-
line phosphatase (AP) and osteocalcin, respectively (Supple-
mentary Figure S1 online). Assuming that phenotypic analysis
of adherent dermal cells is informative regarding the nature of
cells capable of mesenchymal differentiation, they were
subjected to analysis by flow cytometry with a selection of
MSC markers. We found that dermis-derived cells express all
mesenchymal markers such as CD10, CD13, CD26, CD29,
CD44, CD71, CD73, CD90, CD105, CD146, and to a
lesser extent CD106, CD271, STRO-1, and SSEA-4, thus
exhibiting the phenotype reported for mesenchymal progeni-
tor cells (Figure 2b; Minguell et al., 2001; Dominici et al.,
2006; Chamberlain et al., 2007). We next compared the
phenotype of adherent dermal cells and bone marrow–
derived cells, both cultured under the same conditions
(Figure 2c), and thereby confirmed the intriguing pheno-
typic similarity of dermis– and bone marrow–derived cells.
The expression of CD29, CD73, CD90, CD105, CD106, and
SSEA-4 was significantly higher on bone marrow–derived
cells (Figure 2c). Dermis– and bone marrow–derived cells
showed either no expression or only negligible expression of
endothelial cell and hematopoietic stem cell markers (CD34,
CD133), co-stimulatory molecules for T-cell activation
(CD80, CD86), leukocyte maturation markers (CD83), and
HLA-DR. Only the leukocyte common antigen CD45
was expressed on significantly more dermis-derived
cells. Virtually all cells expressed HLA-ABC, whereas HLA-
DR expression was hardly detectable on either cell type. Half
of the dermis–and bone marrow–derived cells were CD318þ
(Figure 2c). The fact that CD318 can be detected on certain
subsets of mesenchymal stromal cells has been reported
previously (Battula et al., 2008). Interestingly, under
adipogenic culture conditions, virtually every adherent bone
marrow–derived cell differentiated, whereas only a propor-
tion of adherent dermal cells formed adipocytes (Figure 2d).
CD73þ cells show a significantly higher adipogenic
differentiation capacity than CD90þ cells
Multicolor flow cytometry analysis of the expression of MSC
markers on adherent dermal cells revealed that CD73 and
CD105 are co-expressed. Co-expression of CD73 and CD105
was also observed in freshly isolated dermal cells (Supple-
mentary Figure S2 online). CD90, in contrast, was not
expressed on all adherent dermal cells, as a minor population
of the CD73þ cells is CD90 (Figure 3a). CD271þ cells were
CD73þ and CD105þ , whereas the majority of CD271þ cells
were CD90 (Figure 3b, upper panel). Visualization of
CD271þ cells clearly showed their localization within
the CD73þCD105þ cells, whereas only a small subset of
CD73þCD90þ cells expressed CD271 (Figure 3b, lower
panel). This difference between CD73þ and CD90þ dermal
cells with respect to expression of the MSC marker CD271
might reflect different stem/progenitor cell properties. We
therefore directly compared the adipogenic differentiation
capacity of CD73þ and CD90þ cells (purity485%) isolated
from freshly prepared dermal cell suspensions of the same
skin sample to exclude donor-dependent variability and
included the respective unfractionated dermal single-cell
suspensions. We found that the differentiation capacity of
CD73þ cells was significantly higher when compared with
CD90þ cells (896.4±309.1 vs. 323.9±132.8 adipocytes per
well; Po0.006; n¼ 5) and total dermal cells (520.4±139.4
adipocytes per well; Po0.02; Figure 3c, left panel). Interest-
ingly, the differentiation capacity of CD90þ cells is even
significantly lower when compared with total dermal cells
(Po0.04). For control purposes, we also investigated the
differentiation potential of the CD73 (260.4±380.2 adipo-
cytes per well) and CD90 (594±554.9 adipocytes per well)
fractions of the respective experiments (Figure 3c, right
panel). Negative fractions diverged from the respective
positive fractions regarding adipogenic differentiation. How-
ever, the fact that the negative fractions still contained
considerable numbers of positive cells (8–22%) potentially
influences the results.
CD271þ and SSEA-4þ dermal cells reveal high adipogenic
differentiation potential
We showed that the MSC markers CD271 and SSEA-4 are
only expressed on a small subset of adherent dermal cells
(Figure 2b, inset) implying a progenitor cell nature. To test
this hypothesis, the adherent dermal cell fraction was
magnetic-activated cell sorted for CD271þ or SSEA-4þ cells,
which, together with the respective negative and total dermal
cell fraction of the same skin sample, were subjected to
differentiation assays (Figure 4c and b). We found that
CD271þ cells possess a 3- or 2-fold higher adipogenic
differentiation capacity than CD271 (P¼ 0.003, n¼ 5) or
total dermal cells (P¼0.003; Figure 4c and e). As expected,
the number of adipocytes in the CD271 fractions was
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Figure 2. Adherent dermal cells display mesenchymal progenitor cell characteristics. (a) Adherent dermal cells after osteogenic and adipogenic differentiation
stained with Alizarin red and Oil red O, respectively. Photomicrographs of unstained and stained cells were taken (arrowheads indicate osteogenic nodules).
(b) Analysis of adherent dermal cells by flow cytometry (closed profiles: specific staining, open profiles: isotype-matched controls, 2 104 cells displayed,
donor age: 3–9 years). Dead cells were excluded by 7-amino-actinomycin-D uptake. (c) Marker expression profiles of dermal cells (white bars) and bone
marrow–derived cells (gray bars). Error bars indicate mean±SD (n¼4). Significance: *Po0.05, **Po0.01 tested by Mann–Whitney U-test. (d) Oil red O
staining of dermal cells and bone marrow–derived cells after adipogenic differentiation. Bar¼200 mm.
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significantly lower than in total adherent dermal cells
(P¼0.011). Similar to CD271þ cells, SSEA-4þ cells exhibited
a significantly higher adipogenic differentiation potential
than the SSEA-4 fractions (P¼0.049) and total dermal cells
(Figure 4d and f).
CD271þ but not SSEA-4þ dermal cells exhibit osteogenic and
chondrogenic differentiation potential
To evaluate the MSC nature of dermal subpopulations, we
also investigated the osteogenic and chondrogenic differ-
entiation potential of dermal CD271þ and SSEA-4þ cells.
The osteogenic potential was assessed qualitatively by
Alizarin red staining (Figure 5a and b), which revealed strong
staining of the CD271þ fraction in comparison with the
negative and total dermal cell fraction. Comparison of SSEA-
4þ cells with the respective cell fractions, however, did not
show any apparent differences with regard to Alizarin red
staining. Quantitatively we determined osteogenic differen-
tiation by measurement of AP levels (Figure 5c and d).
Significantly higher AP levels in the CD271þ fraction than in
the respective negative (P¼ 0.0278; n¼ 5) and total dermal
cell fractions (P¼0.0129) reflect the high osteogenic
potential of CD271þ cells (Figure 5c). In contrast, we could
not detect any differences in the AP levels when comparing
SSEA-4þ , SSEA-4, and total adherent dermal cells (Figure
5d). Similar to osteogenic differentiation, only CD271þ
dermal cells were able to give rise to typical chondrocytes
(Figure 5e, arrow), whereas they have not been found in the
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Figure 3. CD73þ dermal cells express higher levels of CD271 and have a higher adipogenic differentiation capacity as compared with CD90þ cells.
(a, b) Adherent dermal cells were analyzed by flow cytometry (1 104 cells displayed, donor age: 10 months–7 years, n¼ 4). Red dots (b, lower panel) represent
CD271þ cells. (c) Equal numbers (2 104 cells per well, duplicates) of CD73þ , CD90þ , CD73, and CD90 cells isolated from the same skin sample and
the respective total dermal cells were subjected to adipogenesis and stained with Oil red O. Cells containing lipid vacuoles were counted. Each symbol indicates
the mean of one of five independent experiments (donor age: 5–12 years). Significance: *Po0.05, **Po0.01 tested by a paired t-test. n.s., nonsignificant.
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other investigated cell fractions including SSEA-4þ cells
(Figure 5e). All cell fractions formed a typical chondrogenic
micromass. These differences in the osteogenic and chon-
drogenic potential between CD271þ and SSEA-4þ dermal
cells provide evidence that these populations represent
distinct dermal progenitor cells. Analyses of adherent dermal
cells confirmed that dermal CD271þ and SSEA-4þ cells
mutually exclude each other and seem to represent two
separate populations (Figure 5g).
Our results clearly show that cell populations that possess
divergent mesenchymal differentiation potential can be
isolated from fresh dermal cell suspensions, as well as from
dermal cells preselected by plastic adherence. Among the
cell populations investigated in our study, however, only
CD271þ cells show significantly elevated differentiation
potential in comparison with CD271, as well as total
dermal cells in all differentiation assays performed.
DISCUSSION
We have shown for the first time that distinct populations of
cells expressing MSC markers can be isolated from freshly
separated and adherent cultured dermal cells, which to our
knowledge is previously unreported. On the basis of
comprehensive analysis by immunohistochemistry and flow
cytometry, we isolated three cell populations that exhibit
either significantly elevated mesenchymal differentiation
potential in all three differentiation assays performed
compared with the negative fractions and total dermal cells
(CD271) or show elevated, however, in some respects,
restricted differentiation potential (CD73 and SSEA-4).
MSCs have been isolated from a wide range of tissues
(Erices et al., 2000; Mareschi et al., 2001; Yates et al., 2001;
Young et al., 2001; Fukuchi et al., 2004; Jones et al., 2004;
Bartsch et al., 2005; Miyazaki et al., 2005; Miao et al., 2006;
Mochizuki et al., 2006; Seeberger et al., 2006; Battula et al.,
2007, 2008; Chen et al., 2007; Gallo et al., 2007; Gimble
et al., 2007; Lysy et al., 2007). Assessment of the expression
of MSC markers in widely hair follicle–free skin revealed that
antigens frequently used for the characterization of MSCs in
various tissues are also expressed in human dermis, and that
their expression evidently overlaps with other lineages such
as endothelial cells, leukocytes, keratinocytes, and neural
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structures. These findings emphasize the difficulty of identify-
ing MSCs in freshly prepared tissues and imply the necessity
of preselecting the dermal stromal fraction by plastic
adherence. There exist concerns that the typical properties
of MSCs are culture phenomena, most importantly because
only few studies use noncultured MSCs as reviewed by
Javazon et al. (2004). Our experiments investigating the
differentiation capacity of CD73þ cells isolated from freshly
prepared dermal single-cell suspensions indicate that this cell
fraction is enriched for MSCs in comparison with CD90þ
cells. This demonstrates that cells with MSC characteristics
can directly be isolated from the dermis using specific
antibodies without preselection by plastic adherence. Simi-
larly, CD105þ cells were isolated from noncultured bone
marrow aspirates, showing that CD105þ cells form signifi-
cantly higher numbers of colony-forming unit-F in compar-
ison with unseparated bone marrow mononuclear cells
(Majumdar et al., 2000; Aslan et al., 2006; Kastrinaki et al.,
2008) supporting our results attributing MSC characteristics to
freshly isolated dermal CD73þ cells, which are also
CD105þ .
A comparison of the cell surface makers of adherent
dermal– and bone marrow–derived MSCs revealed that these
two cell types have very similar marker expression profiles
(Ishii et al., 2005; Wagner et al., 2005). CD271 and SSEA-4
expression might point toward a progenitor nature compared
with terminally differentiated fibroblasts, particularly because
both molecules have been previously reported as promising
markers for the isolation of MSCs from bone marrow (Jarocha
et al., 2008).
We found that isolated CD271þ and SSEA-4þ dermal
adherent cells were significantly more prone to undergo
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adipogenesis than their respective negative fractions. More-
over, a correlation between the percentage of CD271þ
and SSEA-4þ cells and their differentiation capacity was
identified. Interestingly, CD271þ cells exhibited elevated
osteogenic and chondrogenic differentiation potential as
compared with the negative and total adherent cell fractions.
SSEA-4þ cells did not differ from the related cell fractions,
indicating the existence of distinct subtypes of MSCs in
human dermis. Only cells within the adherent CD271þ
dermal cell population fulfil the proposed criteria of multi-
potent MSCs (Dominici et al., 2006) with (i) adherence to
plastic and (ii) differentiation potential in vitro into osteo-
blasts, adipocytes, and chondrocytes. The observation that
CD271þ cells exhibiting a stem cell character exist, apart
from bone marrow, also in other tissues is corroborated by a
report about MSCs derived from human synovium (Jones
et al., 2008). In line with our results, CD271þ cells isolated
from human synovium have a clearly elevated mesenchymal
differentiation capacity.
The anatomical niche for cutaneous MSCs is not entirely
clear. The follicular connective sheath and the papilla have
been considered to represent the site of dermal MSCs (Lako
et al., 2002; Richardson et al., 2005; Hoogduijn et al., 2006;
Kruse et al, 2006). Less is known about the distribution of
MSCs in hair follicle–free dermis. This study and others
provide evidence for the occurrence of dermal stem cells in
human foreskin independent of hair follicles (Toma et al.,
2005; Chen et al., 2007; Lorenz et al., 2008). It is conceivable
that dermal MSCs are located in a perivascular pattern, which
has been shown for a variety of organs (Crisan et al.,
2008; Morikawa et al, 2009). Owing to their localization and
their expression of CD146, these cells might be related
to pericytes. CD146 is expressed on pericytes (Crisan
et al., 2008) and all types of human endothelial cells
(Bardin et al., 2001). It may be speculated that also the
dermal MSCs characterized in this study are of perivascular
origin, because B20% of adherent dermal cells expressed
CD146 while lacking endothelial markers CD31 and CD34
(not shown).
It is conceivable that because of their morphological
similarity, dermal MSCs are present among already well-
studied fibroblast subsets. The functional heterogeneity of
morphologically homogenous fibroblast cultures has already
been described (Goldring et al., 1990; Sorrell et al., 2007).
Various studies suggest a role of fibroblasts in angiogenesis
after injury and support of vascular endothelial cell differ-
entiation and basement membrane formation (Sorrell et al.,
2007, 2008; Salvolini et al., 2010). The regenerative role of
fibroblasts has also been shown in a comprehensive study
using a skin reconstruction model (Aoki et al., 2004). It
remains to be determined whether these regenerative
characteristics are carried by all fibroblasts, or whether they
are reserved to different subsets of progenitor cells residing in
human dermis.
Our study makes an attempt to phenotype, isolate, and
differentiate subpopulations of cells in the human dermis
expressing MSC markers, which to our knowledge is pre-
viously unreported. The results might also have an impact on
our understanding of certain aspects in dermatopathology as
dermal MSCs potentially have a role in the evolution of skin
neoplasms (Sellheyer and Krahl, 2010).
MATERIALS AND METHODS
Skin samples
Foreskin samples (donor age: 10 months–12 years) were obtained as
discarded material from routine circumcisions according to the
Declaration of Helsinki principles, and following approval by the
local ethics committee and informed written consent by the parents.
Preparation and culture of dermal single-cell suspensions and
bone marrow–derived MSCs
Skin samples were depleted of subcutaneous tissue and incubated on
1.2Uml1 Dispase II (Roche Applied Science, Penzberg, Germany)
in phosphate-buffered saline (Gibco, Eugene, OR) overnight at
4 1C. The dermis was separated from the epidermis and digested in
0.71Uml1 Liberase Blendzyme 3 (Roche Applied Science) for
90minutes at 37 1C in a shaking water bath. Cells were passed
through a 40-mm cell strainer and either directly processed for flow
cytometric analysis or magnetic-activated cell sorting or plated in
225-cm2 tissue culture flasks (Nunc, Roskilde, Denmark) containing
mesenchymal growth medium (a-MEM (Gibco) supplemented with
10% fetal calf serum (PromoCell, Heidelberg, Germany), 100Uml1
penicillin, and 100mgml1 streptomycin (Gibco)). Nonadherent cells
were removed by medium changes every 48hours. Adherent cells
were grown until they reached 80% confluence, trypsinized, and
subjected to magnetic-activated cell sorting and/or flow cytometry.
Bone marrow–derived MSCs were prepared as described
(Schallmoser et al., 2008). For flow cytometry and differentiation
experiments, cryopreserved cells were thawed, plated in tissue
culture flasks containing mesenchymal growth medium, and grown
to 80% confluence.
Magnetic-activated cell sorting
Freshly prepared dermal cells were labeled with phycoerythrin (PE)-
anti-CD73 (AD2; BD Biosciences, San Jose, CA) and PE-anti-CD90
(5E10; BD Biosciences), incubated with anti-PE-microbeads (Milte-
nyi Biotec, Bergisch Gladbach, Germany), and further processed
according to the manufacturer’s instructions. In another series of
experiments, cultured cells were trypsinized, labeled with biotiny-
lated anti-CD271 (BD Biosciences), or purified anti-SSEA-4 (MC813-
70; Millipore, Billerica, MA) and biotinylated goat anti-mouse IgG
(Hþ L) (Caltag, Buckingham, UK), followed by incubation with anti-
biotin microbeads.
Flow cytometry
Freshly prepared or cultured cells were analyzed using the following
mAbs: PE-anti-CD26 (M-A261), allophycocyanin (APC)-anti-CD29
(MAR4), PE-anti-CD44 (515), APC-anti-CD71 (M-A712), PE-anti-
CD73 (AD2), FITC-anti-CD80 (L307.4), FITC-anti-CD83 (HB15e),
FITC-anti-CD86 (2331), FITC- and PE-anti-CD90 (5E10), APC-anti-
CD106 (51-10C9), PE-anti-CD146 (P1H12), APC- and PE-anti-
CD271 (C40-1457), APC-anti-CD318 (CUB1), FITC-anti-HLA-ABC
(G46-2.6), APC-anti-HLA-DR (L243) (all from BD Biosciences),
FITC-anti-CD10 (SS2/36; Dako, Glostrup, Denmark), FITC-anti-
CD13 (5-390; provided by Dr Otto Majdic, Institute of Immunology,
Medical University of Vienna, Austria), APC- and PE-Cy7-anti-CD45
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(J33; Immunotech, Fullerton, CA), APC- and FITC-anti-CD34
(AC136), PE-anti-CD133 (AC141; both Miltenyi Biotec), FITC- and
PE-anti-CD105 (166707), PE-anti-SSEA-4 (MC813-70; R&D Systems,
Minneapolis, MN), FITC-anti-CD31 (WM59), and PE-anti-STRO-1
(STRO-1; Serotec, Kidlington, UK). Appropriate isotype controls
were included and gates were set according to isotype-matched
controls. Dead cells were excluded with 7-amino-actinomycin-D
(Calbiochem, Darmstadt, Germany). Analysis of cells was performed
on a LSR-II (BD Biosciences) and data were evaluated using the
FlowJo software (Tree Star, Ashland, OR).
In vitro differentiation assays
For adipogenic differentiation, cells (2 104 cells per well) were
seeded in 48-well plates in duplicates and cultured in mesenchymal
growth medium. Upon reaching confluence, adipogenic induction
medium (mesenchymal growth medium supplemented with 0.2mM
indomethacin, 0.1 mM dexamethasone, 0.5mM 3-isobutyl-1-methyl-
xanthine, and 10 mgml1 recombinant human insulin (all from
Sigma-Aldrich, St Louis, MO)) was applied for 21 days. Cells were
fixed in 4% paraformaldehyde (Sigma-Aldrich) and stained with Oil
red O (Sigma-Aldrich). The differentiated cells were counted and
statistically analyzed.
For osteogenic differentiation, confluent cells (48-well plate,
duplicates) were stimulated with osteogenic induction medium
(mesenchymal growth medium supplemented with 0.1mM dexame-
thasone, 50mgml1 ascorbic acid and 10mM glycerol 2-phosphate
(all from Sigma-Aldrich)) for 21 days and then either stained with
Alizarin red (Sigma-Aldrich) or subjected to an AP assay. For this,
cells were lysed (CelLytic M; Sigma-Aldrich) and the supernatant was
subjected to analysis by a fluorometric AP Detection Kit (Sigma-
Aldrich) according to the manufacturer’s instructions.
For chondrogenic differentiation, cells (2.5 105) were placed in
chondrogenic medium (D-MEM/F-12 medium containing 2mM
L-glutamine, 100mgml1 sodium pyruvate, 0.1mM nonessential amino
acids (all from Gibco), 1% insulin transferrin sodium selenite plus,
50mgml1 ascorbic acid 2-phosphate, 0.1mM dexamethasone (all from
Sigma-Aldrich), 10ngml1 TGFb3 (R&D Systems)), centrifuged at 450g
for 5minutes, and pellets were cultivated for 21 days. Micromasses
were fixed in 4% paraformaldehyde, embedded in O.C.T. (Tissue-Tek,
Sakura Finetek, Zoeterwoude, The Netherlands), cut into 5mm
sections, stained with toluidine blue (Sigma-Aldrich), and analyzed.
Negative controls, in which media supplements inducing
differentiation were omitted, were included for each differentiation
assay and did not show spontaneous differentiation. Moreover,
adipogenic and osteogenic differentiation of adherent dermal
cells in contrast to negative controls was confirmed by molecular
analysis of the expression of peroxisome proliferator–activated
receptor-g-2 or AP and osteocalcin, respectively (Supplementary
Figure S1 online).
Immunohistochemistry
Skin sections (4 mm) were fixed in ice-cold acetone for 10minutes
and air-dried. Purified primary antibodies (anti-CD73 (AD2), anti-
CD90 (5E10), anti-CD271 (C40-1457) (all from BD Biosciences)),
anti-CD105 (166707), anti-SSEA-4 (MC813-70; R&D Systems), and
isotype controls were diluted in 2% BSA/phosphate-buffered saline,
applied to the sections, and incubated overnight at 4 1C. Endogenous
peroxidase was blocked by incubation with 0.03% hydrogen
peroxide/methanol (room temperature, 10minutes). Subsequently,
sections were incubated with biotin-conjugated goat anti-mouse IgG
(room temperature, 60minutes) using the Elite mouse IgG Vectastain
Kit (Vector Laboratories, Burlingame, CA). Biotinylated antibodies
were detected with horseradish peroxidase–streptavidin and visua-
lized with amino-ethyl-carbazole (Dako). Sections were counter-
stained with hematoxylin. Photomicrographs were taken using an
Eclipse 80 microscope (Nikon, Tokyo, Japan).
Immunofluorescence
Freshly isolated dermal cells were cultured in eight-well-chamber
slides (Lab-Tek; Nunc) for 5 days. Adherent cells were fixed with
methanol and incubated with APC-anti-CD271 (C40-1457; BD
Biosciences), PE-anti-SSEA-4 (MC813-70; R&D Systems), and
isotype controls diluted in 2% BSA/phosphate-buffered saline
overnight at 4 1C. Slides were mounted using Vectashield (Vector
Laboratories) and images were recorded using a confocal laser
scanning microscope (LSM 410; Carl Zeiss, Jena, Germany).
Statistical analysis
Differences between groups were assessed using the Mann–Whitney U-
test or a paired t-test for related groups, respectively (GraphPad
Software, La Jolla, CA). The reported P-value is a result of a two-sided
test. A P-value below 5% was considered statistically significant.
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